Arbutus Biopharma
$3.189876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.46 (-12.71%) As of 7:41 PM UTC today
Why Robinhood?
You can buy or sell ABUS and other stocks, options, and ETFs commission-free!
About ABUS
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The listed name for ABUS is Arbutus Biopharma Corporation Common Stock.
CEO
William H. Collier
Employees
80
Headquarters
Warminster, Pennsylvania
Founded
2005
Market Cap
258.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.72M
High Today
$3.60
Low Today
$3.01
Open Price
$3.60
Volume
3.83M
52 Week High
$9.02
52 Week Low
$0.88
ABUS News
Analyst Ratings
71%
of 7 ratings
Buy
71%
Hold
29%
Sell
0%
ABUS Earnings
-$0.73
-$0.49
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.22 per share
Actual
-$0.23 per share